Šiman Pavel, Bezrouk Aleš, Tichá Alena, Kozáková Hana, Hudcovic Tomáš, Kučera Otto, Niang Mohamed
Independent Researcher, Librantická 157, CZ-50003 Hradec Králové, Czech Republic.
Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, CZ-50003 Hradec Králové, Czech Republic.
Pharmaceutics. 2025 Aug 13;17(8):1051. doi: 10.3390/pharmaceutics17081051.
: Betulin is a promising agent in many areas of medicine and is being investigated, particularly in the field of cancer. However, in in vivo experiments, its water insolubility becomes a significant obstacle. This study describes a promising method for the administration of betulin in in vivo experiments and the determination of betulin levels in organ samples. : Betulin was first dissolved in ethanol, and this solution was then mixed with acylglycerols, followed by evaporation of the ethanol. Olive oil and food-grade lard were determined to be suitable lipids for noninvasive application per os. A method for processing the organs of experimental animals for betulin determination was developed. Determination of betulin levels in blood is also likely the only viable option for use in future clinical studies and practice. : The maximum amount of betulin usable (i.e., absorbable by organisms) in olive oil (10 mg/mL), suppository mass (6 mg/mL), food lard (4 mg/mL), and cocoa butter (2 mg/mL) carriers was found microscopically. A specific distribution of betulin concentration in the organs of experimental animals (Wistar rats) after a weekly diet containing betulin was discovered. The blood was shown to be particularly advantageous, as it allows continuous monitoring of betulin levels in the body. In these pilot experiments, a statistically significant ( < 0.001) synergistic effect of betulin on solid Ehrlich adenocarcinoma tumors was observed when betulin was combined with cytostatic Namitecan (NMRI mice). The high-purity betulin used in this study is very stable even under fluctuating storage conditions. : Our study suggests that both the method of betulin administration and the proposed analytical procedure could greatly increase the reliability and reproducibility of in vivo studies, as well as future preclinical and clinical studies on the effects of betulin and potentially other similar water-insoluble triterpenoids on living organisms.
桦木醇在医学的许多领域都是一种有前景的药物,目前正在进行研究,尤其是在癌症领域。然而,在体内实验中,其水不溶性成为一个重大障碍。本研究描述了一种在体内实验中给予桦木醇的有前景的方法以及测定器官样本中桦木醇水平的方法。:首先将桦木醇溶解于乙醇中,然后将该溶液与酰基甘油混合,接着蒸发乙醇。橄榄油和食品级猪油被确定为适合经口无创应用的脂质。开发了一种处理实验动物器官以测定桦木醇的方法。测定血液中的桦木醇水平也可能是未来临床研究和实践中唯一可行的选择。:通过显微镜观察发现了桦木醇在橄榄油(10毫克/毫升)、栓剂基质(6毫克/毫升)、食品猪油(4毫克/毫升)和可可脂(2毫克/毫升)载体中可用(即生物体可吸收)的最大量。发现给予含桦木醇的每周饮食后,实验动物(Wistar大鼠)器官中桦木醇浓度的特定分布。血液显示出特别的优势,因为它允许持续监测体内的桦木醇水平。在这些初步实验中,当桦木醇与细胞抑制剂纳米替康联合使用时(NMRI小鼠),观察到桦木醇对实体艾氏腺癌肿瘤有统计学显著(<0.001)的协同作用。本研究中使用的高纯度桦木醇即使在波动的储存条件下也非常稳定。:我们的研究表明,桦木醇的给药方法和所提出的分析程序都可以大大提高体内研究以及未来关于桦木醇和潜在其他类似水不溶性三萜对生物体影响的临床前和临床研究的可靠性和可重复性。